Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 118Carboplatin 101Paclitaxel 62Cisplatin 56Gemcitabine 55Pemetrexed 52Bevacizumab 49Docetaxel 44Fluorouracil 39Oxaliplatin 37Dexamethasone 34130-nm albumin-bound paclitaxel 33atezolizumab 32Leucovorin 32Cetuximab 31durvalumab 26Nivolumab 25Capecitabine 25Rituximab 24Prednisone 24Fulvestrant 23Cyclophosphamide 23Lenalidomide 22enzalutamide 21venetoclax 20Irinotecan 19Letrozole 18pomalidomide 16apalutamide 16daratumumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Receptors, Vascular Endothelial Growth Factor × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡